Virtue Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Sell |
1,506
-178
| -11% | -$38.9K | 0.06% | 186 |
|
|
2025
Q1 | $377K | Buy |
1,684
+453
| +37% | +$102K | 0.04% | 312 |
|
|
2024
Q4 | $403K | Buy |
1,231
+164
| +15% | +$53.7K | 0.08% | 172 |
|
|
2024
Q3 | $320K | Buy |
1,067
+242
| +29% | +$72.6K | 0.06% | 192 |
|
|
2024
Q2 | $261K | Buy |
825
+61
| +8% | +$19.3K | 0.04% | 308 |
|
|
2024
Q1 | $292K | Buy |
764
+2
| +0.3% | +$764 | 0.05% | 296 |
|
|
2023
Q4 | $258K | Sell |
762
-1,559
| -67% | -$527K | 0.05% | 307 |
|
|
2023
Q3 | $875K | Hold |
2,321
| – | – | 0.15% | 126 |
|
|
2023
Q2 | $875K | Sell |
2,321
-330
| -12% | -$124K | 0.15% | 126 |
|
|
2023
Q1 | $947K | Buy |
2,651
+1,674
| +171% | +$598K | 0.16% | 112 |
|
|
2022
Q4 | $230K | Buy |
+977
| New | +$230K | 0.04% | 337 |
|
|
2022
Q2 | – | Sell |
-4,194
| Closed | -$1.72M | – | 415 |
|
|
2022
Q1 | $1.72M | Sell |
4,194
-1,228
| -23% | -$504K | 0.27% | 82 |
|
|
2021
Q4 | $2.54M | Buy |
5,422
+658
| +14% | +$309K | 0.38% | 56 |
|
|
2021
Q3 | $2.02M | Buy |
4,764
+30
| +0.6% | +$12.7K | 0.36% | 59 |
|
|
2021
Q2 | $1.7M | Sell |
4,734
-492
| -9% | -$177K | 0.34% | 66 |
|
|
2021
Q1 | $1.47M | Buy |
5,226
+115
| +2% | +$32.4K | 0.35% | 68 |
|
|
2020
Q4 | $1.45M | Sell |
5,111
-386
| -7% | -$109K | 0.36% | 77 |
|
|
2020
Q3 | $1.51M | Sell |
5,497
-536
| -9% | -$147K | 0.37% | 77 |
|
|
2020
Q2 | $1.37M | Buy |
+6,033
| New | +$1.37M | 0.32% | 92 |
|
|
2020
Q1 | – | Sell |
-4,044
| Closed | -$608K | – | 215 |
|
|
2019
Q4 | $608K | Buy |
4,044
+1,220
| +43% | +$183K | 0.18% | 113 |
|
|
2019
Q3 | $400K | Buy |
2,824
+1,126
| +66% | +$159K | 0.13% | 162 |
|
|
2019
Q2 | $213K | Buy |
+1,698
| New | +$213K | 0.08% | 201 |
|